SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-23-270366
Filing Date
2023-11-03
Accepted
2023-11-03 16:04:50
Documents
9
Period of Report
2023-12-15

Document Format Files

Seq Description Document Type Size
1 PRE 14A d545726dpre14a.htm PRE 14A 1309892
2 GRAPHIC g545726dsp140.jpg GRAPHIC 196543
3 GRAPHIC g545726dsp141.jpg GRAPHIC 176859
4 GRAPHIC g545726g00a22.jpg GRAPHIC 22246
5 GRAPHIC g545726g01k02.jpg GRAPHIC 61213
6 GRAPHIC g545726g03a03.jpg GRAPHIC 130816
7 GRAPHIC g545726g49u01.jpg GRAPHIC 28266
8 GRAPHIC g545726g62x92.jpg GRAPHIC 26613
9 GRAPHIC g545726g77a67.jpg GRAPHIC 36470
  Complete submission text file 0001193125-23-270366.txt   2235151
Mailing Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE
Business Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE 44 29 2071 0570
Renalytix plc (Filer) CIK: 0001811115 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: PRE 14A | Act: 34 | File No.: 001-39387 | Film No.: 231376276
SIC: 8071 Services-Medical Laboratories